13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q1 2017. See the latest, Q2 2026 →
Reported value
$317.04B
+2.8% on the quarter before
Positions
425
30 new · 32 sold out
Top 10
24.0%
of the value
Est. gain
+$18.01B
on stocks held all quarter
Est. return
+6.4%
on those stocks since Q4 2016
Positions as of Mar 31, 2017, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 40% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2016. Striped tiles are options.
Largest buys
Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Abbott Laboratories~$1.12BAdded · 0.1% → 0.5%+25,159,924 shares
- Kellogg Co~$900.4MAdded · 0.1% → 0.4%+12,400,257 shares
- Teva Pharmaceutical Industries Ltd ADR~$727.4MAdded · 0.5% → 0.7%+22,667,886 shares
- Wells Fargo And Co~$703.7MAdded · 0.5% → 0.7%+12,642,923 shares
- Alphabet~$608.9MAdded · 0.9% → 1.1%+718,236 shares
- Kimberly-Clark Corp~$572.1MAdded · 0.1% → 0.3%+4,346,352 shares
- Apple~$502.3MAdded · 0.8% → 1.2%+3,496,654 shares
- Bbandt Corporation~$453.5MAdded · 0.3% → 0.4%+10,146,305 shares
- Las Vegas Sands Corp~$442.6MAdded · 0.5% → 0.7%+7,755,002 shares
- Broadcom Ltd~$406.5MAdded · 1.8% → 2.3%+1,856,717 shares
Largest sells
Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amgen Inc~$1.34BCut · 3.1% → 3.0%−8,157,032 shares
- Canadian Natural Resources Ltd~$982.2MCut · 1.3% → 1.0%−29,994,675 shares
- Crown Castle Intl Corp (Reit)~$904.9MCut · 0.8% → 0.6%−9,580,228 shares
- Alexion Pharmaceuticals Inc~$866.8MCut · 0.3% → 0.0%−7,149,175 shares
- Mckesson Corp~$834.7MCut · 0.6% → 0.4%−5,630,295 shares
- Alibaba~$805.4MCut · 1.1% → 1.1%−7,469,421 shares
- AT&T~$632.3MCut · 1.0% → 0.7%−15,216,612 shares
- Coca-Cola Co~$606.6MCut · 0.9% → 0.7%−14,293,054 shares
- Boeing Co~$582.2MCut · 1.0% → 0.9%−3,291,905 shares
- Goldman Sachs~$570.8MCut · 0.7% → 0.5%−2,484,665 shares
Holdings
As of Mar 31, 2017. Changes are in shares against Dec 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie IncCOMMON STOCK · shares +0.7% · price +4.1% | 3.6% | $11.48B | +$444.4M | ||||||||
| AmazonCOMMON STOCK · shares −0.5% · price +18.2% | 3.0% | $9.46B | +$1.46B | ||||||||
| Amgen IncCOMMON STOCK · shares −12% · price +12.2% | 3.0% | $9.41B | +$1.02B | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares −5.5% · price +23.4% | 2.5% | $7.86B | +$1.49B | ||||||||
| NetflixCOMMON STOCK · shares −2.4% · price +19.4% | 2.4% | $7.47B | +$1.21B | ||||||||
| Broadcom LtdCOMMON STOCK · shares +5.8% · price +23.9% | 2.3% | $7.36B | +$1.34B | ||||||||
| OracleCOMMON STOCK · shares −0.9% · price +16.0% | 2.1% | $6.76B | +$932.9M | ||||||||
| Verizon Communications IncCOMMON STOCK · shares −5.7% · price −8.7% | 2.1% | $6.50B | −$617.4M | ||||||||
| Altria Group IncCOMMON STOCK · shares +0.5% · price +5.6% | 1.5% | $4.89B | +$258.9M | ||||||||
| American International Group IncCOMMON STOCK · shares −0.4% · price −4.4% | 1.5% | $4.85B | −$223.5M | ||||||||
| Texas InstrumentsCOMMON STOCK · shares −7.8% · price +10.4% | 1.5% | $4.76B | +$448.3M | ||||||||
| Union Pacific CorpCOMMON STOCK · shares −1.4% · price +2.2% | 1.4% | $4.47B | +$94.4M | ||||||||
| IntelCOMMON STOCK · shares +6.1% · price −0.6% | 1.3% | $4.25B | −$22.2M | ||||||||
| Stryker CorpCOMMON STOCK · shares −9.6% · price +9.9% | 1.3% | $4.09B | +$367.6M | ||||||||
| AlphabetCOMMON STOCK · shares +8.1% · price +7.5% | 1.3% | $4.01B | +$257.8M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −9.3% · price +2.5% | 1.2% | $3.80B | +$91.9M | ||||||||
| AppleCOMMON STOCK · shares +16% · price +24.0% | 1.2% | $3.68B | +$615.5M | ||||||||
| AlphabetCOMMON STOCK · shares +21% · price +7.0% | 1.1% | $3.57B | +$193.1M | ||||||||
| Eog Resources IncCOMMON STOCK · shares −6.8% · price −3.5% | 1.1% | $3.56B | −$129.5M | ||||||||
| AlibabaCOMMON STOCK · shares −19% · price +22.8% | 1.1% | $3.55B | +$658.3M | ||||||||
| Accenture Plc Cl ACOMMON STOCK · shares −1.7% · price +2.3% | 1.1% | $3.34B | +$76.7M | ||||||||
| Canadian Natural Resources LtdCOMMON STOCK · shares −23% · price +2.7% | 1.0% | $3.29B | +$87.9M | ||||||||
| General Dynamics CorpCOMMON STOCK · shares −0.1% · price +8.4% | 0.95% | $3.01B | +$233.6M | ||||||||
| Home Depot IncCOMMON STOCK · shares +0.03% · price +9.5% | 0.92% | $2.92B | +$253.1M | ||||||||
| Boeing CoCOMMON STOCK · shares −17% · price +13.6% | 0.90% | $2.86B | +$341.9M | ||||||||
| Total · 425 positions | 100% | $317.04B | +$18.01B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2016 to Q1 2017: 394 stocks held throughout, up $18.01B (+6.4%).
- Philip Morris International+$1.49B+23%
- Amazon+$1.46B+18%
- Broadcom Ltd+$1.34B+24%
- Netflix+$1.21B+19%
- Amgen Inc+$1.02B+12%
- American International Group Inc−$223.5M−4%
- Exxon Mobil Corp−$243.5M−9%
- Halliburton Co−$267.4M−9%
- Kroger Co−$459.1M−15%
- Verizon Communications Inc−$617.4M−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |